IRIDEX Net Profit Margin 2010-2024 | IRIX
IRIDEX net profit margin from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
| IRIDEX Net Profit Margin Historical Data |
| Date |
TTM Revenue |
TTM Net Income |
Net Margin |
| 2024-09-30 |
$0.05B |
$-0.01B |
-22.45% |
| 2024-06-30 |
$0.05B |
$-0.01B |
-22.00% |
| 2024-03-31 |
$0.05B |
$-0.01B |
-22.00% |
| 2023-12-31 |
$0.05B |
$-0.01B |
-19.23% |
| 2023-09-30 |
$0.06B |
$-0.01B |
-14.55% |
| 2023-06-30 |
$0.06B |
$-0.01B |
-14.04% |
| 2023-03-31 |
$0.06B |
$-0.01B |
-12.07% |
| 2022-12-31 |
$0.06B |
$-0.01B |
-12.28% |
| 2022-09-30 |
$0.06B |
$-0.01B |
-14.04% |
| 2022-06-30 |
$0.06B |
$-0.01B |
-14.55% |
| 2022-03-31 |
$0.05B |
$-0.01B |
-9.26% |
| 2021-12-31 |
$0.05B |
$-0.01B |
-9.43% |
| 2021-09-30 |
$0.05B |
$-0.00B |
-6.00% |
| 2021-06-30 |
$0.05B |
$-0.00B |
-6.52% |
| 2021-03-31 |
$0.04B |
$-0.01B |
-17.95% |
| 2020-12-31 |
$0.04B |
$-0.01B |
-19.44% |
| 2020-09-30 |
$0.04B |
$-0.01B |
-25.00% |
| 2020-06-30 |
$0.04B |
$-0.01B |
-23.68% |
| 2020-03-31 |
$0.04B |
$-0.01B |
-19.05% |
| 2019-12-31 |
$0.04B |
$-0.01B |
-20.45% |
| 2019-09-30 |
$0.04B |
$-0.01B |
-23.26% |
| 2019-06-30 |
$0.04B |
$-0.01B |
-25.58% |
| 2019-03-31 |
$0.04B |
$-0.01B |
-27.91% |
| 2018-12-31 |
$0.04B |
$-0.01B |
-30.95% |
| 2018-09-30 |
$0.04B |
$-0.02B |
-36.59% |
| 2018-06-30 |
$0.04B |
$-0.02B |
-36.59% |
| 2018-03-31 |
$0.04B |
$-0.02B |
-36.59% |
| 2017-12-31 |
$0.04B |
$-0.01B |
-31.71% |
| 2017-09-30 |
$0.04B |
$-0.02B |
-43.18% |
| 2017-06-30 |
$0.04B |
$-0.02B |
-39.53% |
| 2017-03-31 |
$0.05B |
$-0.01B |
-31.11% |
| 2016-12-31 |
$0.05B |
$-0.01B |
-25.53% |
| 2016-09-30 |
$0.05B |
$-0.00B |
-2.17% |
| 2016-06-30 |
$0.05B |
0 |
0.00% |
| 2016-03-31 |
$0.04B |
$-0.00B |
-2.33% |
| 2015-12-31 |
$0.04B |
$-0.00B |
-2.38% |
| 2015-09-30 |
$0.04B |
$0.01B |
19.05% |
| 2015-06-30 |
$0.04B |
$0.01B |
19.05% |
| 2015-03-31 |
$0.04B |
$0.01B |
20.45% |
| 2014-12-31 |
$0.04B |
$0.01B |
20.93% |
| 2014-09-30 |
$0.04B |
0 |
0.00% |
| 2014-06-30 |
$0.04B |
$0.00B |
2.38% |
| 2014-03-31 |
$0.04B |
$0.00B |
2.50% |
| 2013-12-31 |
$0.04B |
$0.00B |
5.13% |
| 2013-09-30 |
$0.04B |
$0.00B |
5.41% |
| 2013-06-30 |
$0.04B |
0 |
0.00% |
| 2013-03-31 |
$0.03B |
0 |
0.00% |
| 2012-12-31 |
$0.03B |
$0.00B |
3.03% |
| 2012-09-30 |
$0.03B |
$0.00B |
6.06% |
| 2012-06-30 |
$0.03B |
$0.00B |
9.09% |
| 2012-03-31 |
$0.03B |
$0.00B |
12.12% |
| 2011-12-31 |
$0.03B |
$0.00B |
9.09% |
| 2011-09-30 |
$0.03B |
$0.00B |
12.00% |
| 2011-06-30 |
$0.03B |
$0.00B |
14.29% |
| 2011-03-31 |
$0.03B |
$0.00B |
13.33% |
| 2010-12-31 |
$0.03B |
$0.00B |
9.09% |
| 2010-09-30 |
$0.03B |
$0.00B |
9.68% |
| 2010-06-30 |
$0.03B |
$0.00B |
10.00% |
| 2010-03-31 |
$0.03B |
$0.00B |
9.68% |
| 2009-12-31 |
$0.03B |
$0.00B |
9.68% |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Laser Systems and Components |
$0.029B |
$0.052B |
|
IRIDEX Corporation is the leading worldwide provider of semiconductor-based laser systems used to treat eye diseases in ophthalmology and skin lesions in dermatology. The products are sold in the United States predominantly through a direct sales force and internationally through independent distributors. The company markets the products using three brand names: IRIS Medical to the ophthalmology market, IRIDERM to the dermatology market, and Light Solutions to the research market.
|
